HEBECELL
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases the company's mission is to contribute to the fields of regenerative medicine and immuno-oncology by developing cell-based therapeutics. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.
HEBECELL
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.hebecellcorp.com
Total Employee:
11+
Status:
Active
Contact:
+1 508 545 2190
Email Addresses:
[email protected]
Total Funding:
63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Creative BioTherapeutics
Creative BioTherapeutics discovers treatments for patients with incurable diseases.
EchoPixel
EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
FimmCyte
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Longeviti
Longeviti develops and commercializes implantable neurosurgical devices.
Okami Medical
Okami Medical develops and commercializes new devices for the treatment of heart disease.
Z.M.D. Medical
Z.M.D. Medical develops and commercializes a therapeutic remedy to cure cancer of all types using the immune system.
Current Employees Featured
Founder
Investors List
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals investment in Series A - HebeCell
Aceso Biotech Venture Fund
Aceso Biotech Venture Fund investment in Seed Round - HebeCell
Official Site Inspections
http://www.hebecellcorp.com Semrush global rank: 6.56 M Semrush visits lastest month: 954
- Host name: ded5116.inmotionhosting.com
- IP address: 173.231.203.136
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "HebeCell" on Search Engine
About – Hebecellcorp
WE ARETHECUTTINGEDGE. WE ARE. THE. CUTTING. EDGE. World-leading researchers. Expert entrepreneurs. State-of-the-art facilities. HebeCell was founded in 2016 by a group of scientists who wanted to …See details»
HebeCell - Crunchbase Company Profile & Funding
Legal Name HebeCell Corp. Company Type For Profit. Contact Email [email protected]. Phone Number +1 508 545 2190. HebeCell develops and commercializes cell-based …See details»
Collaboration – Hebecellcorp
Proteintech and HebeCell entered into a collaborative partnership on November 11th, 2020 to develop proprietary nanobody based chimeric antigen receptor (nCAR) technology for …See details»
HebeCell Raises $53 Million in Series A Financing to …
August 31, 2021 03:51 PM Eastern Daylight Time. NATICK, Mass.-- ( BUSINESS WIRE )--HebeCell Corp (“HebeCell”) today announced that it has successfully closed a US$53 million Series A financing...See details»
HebeCell and Logomix Announce Collaboration for the …
Aug 11, 2023 BOSTON & TOKYO-- ( BUSINESS WIRE )--HebeCell Corp (HebeCell), a biotechnology company developing Proto NK™ cell therapeutics based on its proprietary …See details»
HebeCell Corp | LinkedIn
HebeCell is a Natick, MA based biotech company that focuses on immuno-oncology and regenerative medicine. View all 20 employees. About us. HebeCell was founded in 2016 …See details»
HebeCell and Logomix Announce Collaboration for the …
BOSTON & TOKYO, August 11, 2023 -- ( BUSINESS WIRE )--HebeCell Corp (HebeCell), a biotechnology company developing Proto NK™ cell therapeutics based on its proprietary …See details»
HebeCell lands $53M, Chinese collaborator to make a splash in …
Sep 1, 2021 HebeCell is the latest biotech to grow its bank balance, raising $53 million in a round led by a Chinese drug developer to advance its off-the-shelf CAR-NK prospects. …See details»
HebeCell - Funding, Financials, Valuation & Investors - Crunchbase
HebeCell has raised a total of. $63M. in funding over 2 rounds. Their latest funding was raised on Aug 31, 2021 from a Series A round. HebeCell is funded by 2 investors. …See details»
News – Hebecellcorp
Apr 24, 2020 HebeCell Corp (“HebeCell”) today announced that it has closed a US$10 million Pre-Series A financing to further advance the research and development of its leading patented scalable natural killer …See details»
HebeCell and Logomix Announce Collaboration for the
Aug 11, 2023 BOSTON & TOKYO-- ( BUSINESS WIRE )-- HebeCell Corp (HebeCell), a biotechnology company developing Proto NK™ cell therapeutics based on its proprietary …See details»
Jacobio Announces Strategic Investment in Hebecell to Further …
Aug 31, 2021 BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals ("Jacobio", 1167.HK) announced a strategic investment in the …See details»
HebeCell Company Profile 2024: Valuation, Funding & Investors
HebeCell Overview. Update this profile. Year Founded. 2016. Status. Private. Employees. 20. Latest Deal Type. Series A. Latest Deal Amount. $53M. Investors. 3. General …See details»
HebeCell Raises $53 Million in Series A Financing to Advance …
NATICK, Mass.– (BUSINESS WIRE)–HebeCell Corp (“HebeCell”) today announced that it has successfully closed a US$53 million Series A financing to advance its unique off-the …See details»
Series A - HebeCell - 2021-08-31 - Crunchbase Funding Round …
Aug 31, 2021 Overview. Organization Name. HebeCell. Announced Date Aug 31, 2021. Funding Type Series A. Funding Stage Early Stage Venture. Money Raised. $53M. …See details»
Technology – Hebecellcorp
The principle of HebeCell’s methodology is to mimic the natural developmental process of hematopoiesis in human body through formation and subsequent in vitro development of …See details»
HebeCell Raises $53 Million For Stem Cell Research
Sep 1, 2021 HebeCell Corp, founded in 2016, is primarily engaged in developing universal and cost-effective NK cell therapeutics based on its proprietary 3D-pluripotent stem cell …See details»
Jacobio Announces Strategic Investment in Hebecell to Further …
Founded in Boston in 2016, Hebecell is primarily engaged in developing universal, cost-effective and off-the-shelf NK cell therapeutics based on its proprietary 3D-induced …See details»
HebeCell and Logomix Announce Collaboration for the …
Aug 11, 2023 BOSTON & TOKYO-- (BUSINESS WIRE)--HebeCell Corp (HebeCell), a biotechnology company developing Proto NK™ cell therapeutics based on its proprietary …See details»
HebeCell Corp | CipherBio
HebeCell was founded in 2016 by a group of scientists who wanted to push research in regenerative medicine and immuno-oncology farther than ever before. The team of …See details»